Pediatric Neuro-Oncology Program
|
Children’s Hospital of Pittsburgh
|
|
•
|
is committed to
improving the survival rate for children who have
tumors of the
brain and spinal cord
|
|
•
|
provides multidisciplinary
subspecialty clinical care
|
|
•
|
has been a member
of the Children’s Oncology Group since 1961
|
|
•
|
provides access to the newest, most
promising cancer treatments available through its affiliation with
the Children's Oncology Group and the Pediatric Brain Tumor Clinical
Trials Consortium
|
|
•
|
maintains the Neuro-Oncology Research
Program through funding from both the National Institutes of Health
and the National Cancer Institute
|
|
Brain tumors are the leading cause of cancer-related deaths among children.
At Children’s Hospital of Pittsburgh, the Neuro-Oncology Program is committed
to improving the survival rate for children who have
tumors of the brain and/or
spinal cord through state-of-the-art, research-based care. All treatment decisions
are discussed at the Neuro-Oncology Tumor Board by a team of subspecialists
with expertise in the treatment of childhood brain tumors, including staff from
pediatric neurosurgery, radiation oncology, pediatric neuro-oncology and neuroradiology.
Patients often are eligible for treatment in one of many innovative research
protocols at Children’s Hospital. Such protocols provide our patients with access
to new treatment strategies and promising drugs that are available only at a
few centers around the country.
The Neuro-Oncology Research Program at Children’s Hospital is funded in part
by the National Institutes of Health and the National Cancer Institute. Children’s
Hospital of Pittsburgh is part of the Pediatric Brain Tumor Clinical Trials
Consortium, which has as its goal to identify and evaluate novel treatments
and expedite the progress of pediatric neuro-oncological care.
Regina Jakacki, MD, is the director of the Pediatric Neuro-Oncology Program.
She can be reached by calling 412-692-5055.
